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Abstract: The three-dimensional structure of a peptide fusion product with glutathione transferase from
Schistosoma japonicum (SjGST) has been solved by crystallographic methods to 2.5/_, resolution. Peptides or
proteins can be fused to SjGST and expressed in a plasmid for rapid synthesis in Escherichia coli. Fusion
proteins created by this commercial method can be purified rapidly by chromatography on immobilized
glutathione. The potential utility of using SjGST fusion proteins as alternate paths to the crystallization and
structure determination of proteins is demonstrated.
As recombinant technology continues to make advancements, the number of important su'uctural problems
available to structural biologists will expand tremendously placing an increasing emphasis on the crystallization of
important proteins, such as those from the viral genome of the human immunodeficiency virus (HIV).
Crystallization of the latter has been proven particularly difficult; to date structures of only two of the twenty
protein components of HIV- 1 have been reported. Additionally, smaller peptide structures from 8 to 20 amino
acids in length have been historically difficult to crystallize. Strategies employed to favorably effect the solubilities
of such peptides or proteins for crystallization have included the formation of antigen/antibody complexes, the
addition of other substances such as detergents to the crystallization milieu, or, more recently, the chemical
modification of the protein [I]. The formation of fusion )roteins containing the desired peptide or protein of
interest represents an alternative approach and one which\is convenient within the procedure of producing the
recombinant protein. Here we present the serendipitous, bt successful application of this structural approach to
the solution of a hexapeptide fragment of gp41 of HIV-1 wi ich represents a conservative epitope recognized by
the neutralizing human monoclonal antibody 2F5 [2].
Proteins or peptides of interest can be fused with//glutathione S-transferase (GST) and expressed in a
plasmid vector for rapid synthesis in Escherichia coli [3]. Fusion proteins, thus created, can be purified by
affinity chromatography on immobilized glutathione. The system utilizes GST from Schistosomajaponicum
(SjGST), a 26kD protein which as with other GST's, functions as a dimer catalyzing nucleophilic addition of the
reduced sulphydryl to a variety of electrophiles [4]. These reactions are important in the metabolism of potentially
harmful alkylating agents. Because of the rapidity and purity with which the fusion products could be prepared,
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weundertookaseriesof co-crystallizationexperimentswith antibody2F5utilizing a portionof theepitopefused
to SjGST as part of an ongoing effort to further elucidate HIV antigen/antibody complexes [5]. Initial
crystallization attempts of the antibody/antigen complexes were unsuccessful; however, high quality crystals of the
SjGST fusion protein were obtained. The crystals grow in the space group P43212 with a = b = 94.7 ,/k, c = 58.1
from solutions of PEG 3350 MW. The structure has been solved by the molecular replacement method using
coordinates derived fi'om GST of the I.t gene class derived from rat liver (/.tGST) [6] and represents the first
example of an invertebrate GST. SjGST shows 42% sequence identity with/.zGST. The structure is refined
including data to 2.5 ,_ resolution and is notable among GST structures in containing a monomer in the
asymmetric unit and an ordered glutathione in the active site which is providing further insight into GST
chemistry.
Electron density consistent with the hexapeptide fusion product, Glu-Leu-Asp-Lys-Trp-Ala (Fig. 1) has
been observed and incorporated into the ret_ed structure. The conformation of the antigenic peptide is stabilized
by crystal packing interactions with symmetry related molecules (Fig. 2). Although it is possible that the observed
conformation of such a small peptide fragment may not assume its normal secondary structure within gp41, larger
peptides with more stable secondary structure elements, or proteins, should not suffer from this possible
limitation. Still, the tremendous potential of the method is clearly demonstrated. Structure determination of
smaller peptides or protein fusion products with SjGST should be straightforward with the aid of the known
SjGST structure and conventional molecular replacement methods. Larger fusion products which represent more
difficult phasing problem could be overcome by the development of novel iodine or other modified glutathione
based substrates (suggested by the protein complex) [7] or by genetically engineered heavy atom sites within the
SjGST structure, such as in the case of the structure determination of AtGST [6] which can then be utilized for
complimentary phasing by isomorphous replacement methods.
Additional importance of SjGST relates to its Schistosoma origin. Schistosomiasis, a major parasitic
disease, second only to malaria, is estimated to infect over 250 million people worldwide. Since it has been
suggested that the specific inhibition of GST could offer the possibility of combining chemotherapy and
immunotherapy to combat this disease [8, 9]; the determination of other GST members of this parasitic family
may be an attractive approach to the development of a multi-species cross-reactive vaccine against the transmission
of schistosomiasis.
Detailed comparisons of the structure with other members of the GST family will be published [ 10]. Coordinates
of $3(3ST are available from the authors and have been deposited with the Brookhaven Protein Data Bank.
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Figure 1. Stereo view of 2.3 _ omit map of the gp41 fusion peptide contoured
at 2.5 _ level.
wFigure 2. Stereo view of Ca tracing of SjGST with its fusion peptide interacting with
symmetry-related molecules.
